Searched over 200M research papers
10 papers analyzed
These studies suggest that treating angina can involve acupuncture, novel antianginal drugs, optimal medical therapy, percutaneous coronary intervention, surgery, traditional medications like nitrates and calcium-channel blockers, and advanced therapies for refractory cases.
20 papers analyzed
Angina, characterized by chest pain due to myocardial ischemia, is a common symptom of coronary artery disease. Effective management aims to alleviate symptoms, prevent disease progression, and improve patient quality of life. This article synthesizes current research on various treatment modalities for angina, including pharmacological therapies, revascularization techniques, and alternative treatments.
Beta-blockers and calcium channel blockers are the cornerstone of initial pharmacological treatment for angina. Beta-blockers reduce myocardial ischemia by lowering heart rate, while calcium channel blockers achieve this through vasodilation . These drugs are often prescribed together with short-acting nitrates for immediate relief of angina attacks.
Long-acting nitrates, although effective, can lead to tolerance over time. Therefore, they are often used intermittently or in combination with other drugs. Novel antianginal drugs such as ranolazine, ivabradine, and nicorandil offer additional options, particularly for patients who do not respond to traditional therapies .
For acute unstable angina, aspirin and heparin are commonly used to reduce the risk of myocardial infarction. Studies have shown that both drugs significantly lower the incidence of myocardial infarction, with heparin also reducing the occurrence of refractory angina.
When pharmacological treatments are insufficient, revascularization techniques such as PCI and CABG are effective. PCI is often used for patients with high-risk features or those who do not respond to medical therapy, while CABG is preferred for patients with left main coronary artery disease or triple vessel disease .
For refractory angina, advanced revascularization strategies like chronic total occlusion PCI, transmyocardial laser revascularization, and coronary sinus occlusion are being explored. These techniques aim to improve symptoms and quality of life in patients who are not candidates for traditional revascularization.
Acupuncture has shown promise as an adjunctive therapy for chronic stable angina. Studies indicate that acupuncture on disease-affected meridians significantly reduces the frequency of angina attacks compared to non-affected meridians, sham acupuncture, or no acupuncture .
EECP and SCS are non-pharmacological treatments for refractory angina. Both methods have been well-studied and are effective in reducing angina symptoms and improving patient quality of life .
The management of angina involves a multifaceted approach, combining pharmacological treatments, revascularization techniques, and alternative therapies. Beta-blockers, calcium channel blockers, and nitrates remain the mainstay of initial treatment, while novel drugs and revascularization strategies offer additional options for refractory cases. Adjunctive therapies like acupuncture and EECP provide further avenues for symptom relief. By integrating these diverse treatment modalities, healthcare providers can tailor interventions to meet the specific needs of each patient, ultimately improving outcomes and quality of life.
Most relevant research papers on this topic